This company seems to have been delisted
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Athersys
ATHX
0,01187 €
Share price
-33.50%
Change (1 day)
-98.97%
Change (1 year)
Categories
Market capitalization of Athersys (ATHX)
Last known market cap: €0.73 Million
On March 12, 2024 Athersys had a market cap of €0.73 Million. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Athersys from 2007 to 2024
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2024 | €0.8 M | -28.29% |
| 2023 | €1.11 M | -91.71% |
| 2022 | €13.47 M | -92.81% |
| 2021 | €0.18 B | -34.76% |
| 2020 | €0.28 B | 63.79% |
| 2019 | €0.17 B | -3.4% |
| 2018 | €0.18 B | 1.58% |
| 2017 | €0.17 B | 43.28% |
| 2016 | €0.12 B | 58.24% |
| 2015 | €78.86 M | -21.88% |
| 2014 | €0.10 B | -21.11% |
| 2013 | €0.12 B | 200.94% |
| 2012 | €42.51 M | 35.8% |
| 2011 | €31.31 M | -10.93% |
| 2010 | €35.15 M | -35.58% |
| 2009 | €54.56 M | 795.41% |
| 2008 | €6.09 M | -90.43% |
| 2007 | €63.65 M |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | €133.63 B | 18,238,154.29% | 🇺🇸 USA |
 | €109.92 B | 15,002,097.84% | 🇺🇸 USA |
 | €88.32 B | 12,054,075.87% | 🇺🇸 USA |
 | €8.56 B | 1,168,766.84% | 🇺🇸 USA |
 | €326.16 B | 44,514,867.15% | 🇺🇸 USA |
 | €2.30 B | 315,098.65% | 🇺🇸 USA |
 | €5.42 B | 739,854.52% | 🇺🇸 USA |
 | €169.19 B | 23,091,890.92% | 🇺🇸 USA |
 | €111.56 B | 15,225,554.19% | 🇫🇷 France |